Fulgent Genetics, Inc. FLGT Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s operating income?
- Fulgent Genetics, Inc. (FLGT) reported operating income of -$34.62M in Q1 2026.
- How has Fulgent Genetics, Inc.'s operating income changed year-over-year?
- Fulgent Genetics, Inc.'s operating income decreased by 74.9% year-over-year, from -$19.8M to -$34.62M.
- What is the long-term trend for Fulgent Genetics, Inc.'s operating income?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s operating income has grown at a -39.4% compound annual growth rate (CAGR), from $675.95M to -$91.1M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.